Comparative study of sitagliptin with pioglitazone in Japanese type 2 diabetic patients.
Phase of Trial: Phase III
Latest Information Update: 01 May 2013
At a glance
- Drugs Pioglitazone (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms COMPASS
- 03 Sep 2012 Planned number of patients changed from 120 to 130 as reported by University Hospital Medical Information Network - Japan.
- 12 Jun 2012 Results presented at the 72nd Annual Scientific Sessions of the American Diabetes Association.
- 21 Dec 2011 Additional lead trial centre identified as reported by University Hospital Medical Information Network - Japan.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History